Australian fears on "doctor entertaining"

27 November 2006

The pharmaceutical industry in Australia fears a political backlash, after it refused to reveal details of how much it spends on entertaining doctors, according to reports in local newspapers.

They claim that a report commissioned by the drugmakers trade association Medicines Australia from Parker & Partners, a lobbying group, expresses concerns that the federal government could introduce tough rules to severely restrict drug companies' marketing activities in this sector.

According to Parker & Partners, "there is risk of long-term political problems for the industry following Medicine Australia's rejection that its members voluntarily reveal details of such activities to the medical profession."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight